DK0822813T3 - Kombination af en 5-HT-optagelsesinhibitor med en selektiv 5-HT 1A-antagonist - Google Patents

Kombination af en 5-HT-optagelsesinhibitor med en selektiv 5-HT 1A-antagonist

Info

Publication number
DK0822813T3
DK0822813T3 DK96912370T DK96912370T DK0822813T3 DK 0822813 T3 DK0822813 T3 DK 0822813T3 DK 96912370 T DK96912370 T DK 96912370T DK 96912370 T DK96912370 T DK 96912370T DK 0822813 T3 DK0822813 T3 DK 0822813T3
Authority
DK
Denmark
Prior art keywords
antagonist
selective
combination
uptake inhibitor
uptake
Prior art date
Application number
DK96912370T
Other languages
English (en)
Inventor
John Evenden
Seth-Olov Thorberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK0822813T3 publication Critical patent/DK0822813T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
DK96912370T 1995-04-27 1996-04-23 Kombination af en 5-HT-optagelsesinhibitor med en selektiv 5-HT 1A-antagonist DK0822813T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501567A SE9501567D0 (sv) 1995-04-27 1995-04-27 A new combination
PCT/SE1996/000526 WO1996033710A1 (en) 1995-04-27 1996-04-23 A combination of a 5-ht uptake inhibitor with a selective 5-ht1a antagonist

Publications (1)

Publication Number Publication Date
DK0822813T3 true DK0822813T3 (da) 2002-07-29

Family

ID=20398119

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96912370T DK0822813T3 (da) 1995-04-27 1996-04-23 Kombination af en 5-HT-optagelsesinhibitor med en selektiv 5-HT 1A-antagonist

Country Status (29)

Country Link
US (5) US5962514A (da)
EP (1) EP0822813B1 (da)
JP (1) JPH11504037A (da)
KR (1) KR100419810B1 (da)
CN (1) CN1102386C (da)
AR (1) AR002990A1 (da)
AT (1) ATE216579T1 (da)
BR (1) BR9608252A (da)
CA (1) CA2218181A1 (da)
CZ (1) CZ335697A3 (da)
DE (1) DE69620878T2 (da)
DK (1) DK0822813T3 (da)
EE (1) EE03553B1 (da)
ES (1) ES2175089T3 (da)
HU (1) HUP9801946A3 (da)
IL (1) IL117988A0 (da)
IS (1) IS1821B (da)
NO (1) NO317057B1 (da)
NZ (1) NZ306602A (da)
PL (1) PL183997B1 (da)
PT (1) PT822813E (da)
RU (1) RU2183955C2 (da)
SE (1) SE9501567D0 (da)
SK (1) SK282060B6 (da)
TR (1) TR199701254T1 (da)
TW (1) TW458777B (da)
WO (1) WO1996033710A1 (da)
YU (1) YU25696A (da)
ZA (1) ZA962982B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
SE9703374D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
WO1999061014A2 (en) * 1998-05-28 1999-12-02 Sepracor Inc. Compositions and methods employing r(-) fluoxetine and other active ingredients
SE9803155D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
SE9803158D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
SE9803157D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
SE9803156D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
US6331233B1 (en) 2000-02-02 2001-12-18 Honeywell International Inc. Tantalum sputtering target with fine grains and uniform texture and method of manufacture
DE60122015T2 (de) 2000-10-13 2006-11-23 Neurosearch A/S Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz
US20030166554A1 (en) * 2001-01-16 2003-09-04 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US20030185754A1 (en) * 2001-01-16 2003-10-02 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
EA200301195A1 (ru) * 2001-05-01 2004-04-29 Х. Лундбекк А/С Применение энантиомерно чистого эсциталопрама
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
US6855735B2 (en) 2002-03-20 2005-02-15 Temple University Of The Commonwealth System Of Higher Education Ketamine treatment of restless legs syndrome
EP1534258A2 (en) * 2002-08-15 2005-06-01 Wyeth AGONISM OF THE 5HT 2a RECEPTOR FOR TREATMENT OF THERMOREGULATORY DYSFUNCTION
US20050032873A1 (en) * 2003-07-30 2005-02-10 Wyeth 3-Amino chroman and 2-amino tetralin derivatives
US7695601B2 (en) * 2006-05-09 2010-04-13 The United States Of America As Represented By The Secretary Of The Army Electrochemical test apparatus and method for its use
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
WO2015006643A2 (en) * 2013-07-12 2015-01-15 Immuneering Corporation Systems, methods, and environment for automated review of genomic data to identify downregulated and/or upregulated gene expression indicative of a disease or condition
JP7153653B2 (ja) * 2017-02-14 2022-10-14 リサーチ トライアングル インスティテュート プロリン系神経ペプチドｆｆ受容体モジュレーター

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698342A (en) * 1985-07-16 1987-10-06 Serotonin Industries Of Charleston Method and compositions for controlling pain, depression and sedation
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
US5616610A (en) * 1989-12-22 1997-04-01 Astra Aktiebolag (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
TR199701254T1 (xx) 1998-02-21
PL183997B1 (pl) 2002-08-30
CN1187768A (zh) 1998-07-15
US5962514A (en) 1999-10-05
AR002990A1 (es) 1998-05-27
BR9608252A (pt) 1999-05-04
EE03553B1 (et) 2001-12-17
US6184218B1 (en) 2001-02-06
CN1102386C (zh) 2003-03-05
PT822813E (pt) 2002-10-31
CA2218181A1 (en) 1996-10-31
ES2175089T3 (es) 2002-11-16
DE69620878T2 (de) 2002-11-14
AU696356B2 (en) 1998-09-10
SE9501567D0 (sv) 1995-04-27
ZA962982B (en) 1996-10-28
US6172105B1 (en) 2001-01-09
HUP9801946A3 (en) 2000-12-28
KR19990008068A (ko) 1999-01-25
IL117988A0 (en) 1996-08-04
CZ335697A3 (cs) 1998-06-17
EP0822813A1 (en) 1998-02-11
HUP9801946A2 (hu) 2000-05-28
US6184219B1 (en) 2001-02-06
AU5520296A (en) 1996-11-18
NO974921L (no) 1997-12-18
TW458777B (en) 2001-10-11
SK282060B6 (sk) 2001-10-08
EP0822813B1 (en) 2002-04-24
RU2183955C2 (ru) 2002-06-27
EE9700245A (et) 1998-04-15
SK142997A3 (en) 1998-12-02
YU25696A (sh) 1999-06-15
US6169098B1 (en) 2001-01-02
IS1821B (is) 2002-08-27
NO317057B1 (no) 2004-08-02
WO1996033710A1 (en) 1996-10-31
JPH11504037A (ja) 1999-04-06
NZ306602A (en) 1999-04-29
KR100419810B1 (ko) 2004-04-21
HK1002853A1 (en) 1998-09-25
IS4585A (is) 1997-10-09
DE69620878D1 (de) 2002-05-29
NO974921D0 (no) 1997-10-24
PL323083A1 (en) 1998-03-02
ATE216579T1 (de) 2002-05-15

Similar Documents

Publication Publication Date Title
NO974921D0 (no) Kombinasjon av en 5-HT-opptaksinhibitor med en selektiv 5-HT1A antagonist
MA24215A1 (fr) Composes inhibiteurs de squalene-synthetase
ID19602A (id) Piridin tersubstitusi sebagai inhibitor selektif siklooksigenase-2
DK0921923T3 (da) Beskyttelse af rørledningsforbindelser
ID19198A (id) Inhibitor metaloprotease heterosiklik
NO964922D0 (no) Dypvanns-stigerörssammenstilling
ATE269300T1 (de) Calciumrezeptor-inhibitoren
ID18416A (id) Inhibitor metaloprotease diheterosiklik
DE69630842D1 (de) Steinbohrer
DK0799819T3 (da) 1-Dimethylaminomethyl-2-phenylcycloalk-2-enforbindelser med analgesisk virkning
ID18417A (id) Inhibitor ditentat metaloprotease
BR9707514A (pt) Inibidor de neovascularizacão
DE59710208D1 (de) Sanitärarmatur
NO20006255D0 (no) Krystallinsk efavirenz
DK0912321T3 (da) Foring af et rør
IS5155A (is) Fjölgervingur af zópólrestat mónóhýdrati
EE200000143A (et) Selektiivse 5-HT 1A antagonisti kombinatsioon selektiivse h5-HT 1B antagonisti või osalise agonistiga
ID23286A (id) Suatu keran
DE59601868D1 (de) Kreissäge
SI0822813T1 (en) A combination of a 5-ht uptake inhibitor with a selective 5-ht 1a antagonist
BR9610514A (pt) Inibidores cicloantihelmínticos
FR2751646B1 (fr) Phenoxypropanolamine a action antagoniste beta3-adrenergique
EP1007548A4 (en) THROMBIN INHIBITOR FROM TSE-TSE FLY
KR980003990U (ko) 배관용 파이프의 고정구
KR960018156U (ko) 파이프 앵커